Product

Measles Virus is a single negative-strand RNA virus and belongs to a member of Paramyxoviridae. Measles is caused by the measles virus, which is one of the most infectious diseases in human. Clinical measles infection can cause fever, rash and cough. It mainly affects children and young people. Measles can also cause lifelong disability, including brain damage in blindness and deafness. Rubella virus is a single positive strand RNA, which is the only member of the Rubella virus genus. Rubel

Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. The World Health Organization (WHO), on March 11, 2020, declared that COVID-19 could be a pandemic. Anyone can get sick with COVID-19 and become seriously ill or die at any age. Influenza (Flu) is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and lungs. There are three types of influenza viruses: A, B, and C. FluA and FluB are the most common viruses that rout

Respiratory Virus Panel (7) Real Time PCR Kit is intended for the in-vitro qualitative detection of Influenza A virus, Influenza B virus, Respiratory syncytial virus , Human rhinovirus , Respiratory adenovirus, Mycoplasma pneumoniae, Parainfluenza virus nucleic acid in human throat swab samples. 7-in-1 Multiplex PCR assay: Detection and differentiation of 7 viral respiratory pathogens at once, in one run, saving time and resources Reliable: All controls included (positive and negative

The BioPerfectus Allfastra Respiratory Bacteria Panel (7) Real Time PCR Kit is an in vitro diagnostic test, based on multiplexed real-time PCR technology, for the simultaneous qualitative detection and differentiation of nucleic acids from multiple bacterial respiratory organisms(including Haemophilus influenzae, Mycoplasma pneumoniae, Legionella pneumophila, Klebsiella pneumoniae, Streptococcus pneumoniae, Chlamydia pneumoniae and Bordetella pertussis) from the human nasopharyngeal swab, sput

COVID-19 Coronavirus Real Time PCR Kit is an In Vitro Diagnostic (IVD) reagent applying on fluorescent PCR technology and aiming at qualitatively detect Open Reading Frame gene region (ORF1a/b) and viral nucleocapsid region (N) of SARS-CoV-2 RNA from upper and lower respiratory tract specimens. Upper respiratory tract specimens include throat swab and nasopharyngeal swab. Lower respiratory tract specimens include sputum. The product is intended for use on populations suspected to have SARS-C

The Bioperfectus Technologies Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test) is a lateral flow test intended for non-prescription home use with self-collected nasal swab specimens. It is used to detect symptomatic individuals who are suspected of COVID-19 or asymptomatic individuals who have had contact with confirmed COVID-19 patients but do not show any symptoms. Fast: results within 15 minutesEasy to use: prepacked design makes testing more convenientHumanized: all neces

The Bioperfectus Technologies Influenza A and B Viruses Real Time PCR Kit is an in vitro diagnostic test, based on real-time PCR technology, for the detection of Influenza A and B Viruses RNA. Samples can be obtained from throat swab, nasal and pharyngeal secretions and cell culture supernatant. Multiplex real-time PCR detect different target specific for Flu A and Flu B Internal control ensures the whole process reliably Better performance makes the result more accurate More efficient

The BioPerfectus Allfastra Respiratory Bacteria Panel (3) Real Time PCR Kit is an in vitro diagnostic test, based on real-time PCR technology, for the detection of DNA from Pseudomonas aeruginosa, Group A Streptococcus and Staphylococcus aureus. Specimens can be obtained from the human nasopharyngeal swab, sputum and bronchoalveolar lavage fluid. 3-in-1 Multiplex PCR assay detects 3 respiratory bacteria in one tube 96 tests in 46 minutes (on one instrument) Internal control ensures th

COVID-19 Coronavirus and Influenza A/B virus Real Time PCR Kit is an In Vitro Diagnostic (IVD) reagent replying on fluorescent PCR technology and aiming at qualitatively detection and differentiation of RNA from SARS-CoV-2, influenza A virus, and/or influenza B virus from upper and lower respiratory tract samples. Upper and lower respiratory tract samples include throat swab and sputum. Multiplex real-time PCR detect different target specific for SARS-CoV-2, Flu A and Flu B Internal cont

In recent years, outbreaks of novel influenza A virus subtypes have occurred from time to time. For example, the novel influenza A H1N1 virus detected in Mexico in 2009 resulted in a global influenza pandemic. Novel influenza A H1N1 virus (2009) contains gene segments from an avian virus, a swine influenza virus, and a human seasonal influenza virus, leading to significant antigenic changes and causing higher morbidity and mortality. The current laboratory detection methods include virus isola